Patent · US Active

Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells

US8404236B2 · kind B2 · utility

1Cited by
33References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2012
Grant dateMar 26, 2013
Priority date
Expiry dateFeb 13, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/868
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the discovery of antibodies that bind to novel epitopes present on membrane-anchored immunoglobulins and which bind to these novel epitopes on the surface of B cells and plasma cells. In addition, the antibodies of the present invention can mediate ADCC and can be useful to deplete those B cells and plasma cells expressing the novel epitopes of the invention. The antibodies of the present invention can be useful for the treatment of B cell-mediated diseases and diseases caused by monoclonal expansion of B cells. Accordingly the present invention also provides compositions and methods for the prevention, management, treatment or amelioration of B cell-mediated diseases and diseases caused by monoclonal expansion of B cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.